RESEARCH & SCIENCE

What is Ibogaine?

At TheraNova Reset Institute, research isn’t optional; it is the engine behind our clinical precision.

Ibogaine, a plant-derived alkaloid, undergoes a unique metabolic transformation in the body, converting into noribogaine. This compound extends its therapeutic action by interacting with neuroreceptors involved in addiction, emotion, and behavioral regulation. Our medical protocols are built upon an advanced understanding of this process. Guided by real-time data and current neuroscience, we apply targeted strategies that address key receptor systems, including NMDA, kappa-opioid, and serotonin transporters.

What truly sets us apart is the surgical-level expertise of our medical team

Every physician, anesthesiologist, and clinician at TheraNova holds full professional licensing and decades of experience in complex surgical settings. This background gives our team deep familiarity with neuropharmacological response and the precise management of the brain’s receptor systems throughout treatment. Through this blend of research, clinical rigor, and compassionate care, we deliver a science-driven path to real neuroreset with safety as the cornerstone. Unveiling the Subconscious: Ibogaine and the Power of Deep Mental Reprogramming Supporting access to unresolved trauma stored beyond conscious awareness.

While most treatments aim to manage symptoms on the surface

Ibogaine, when clinically administered, may reach deeper neuropsychological layers often shielded from awareness. These include fear-based memory loops, survival programming, and emotional residues that shape long-term behavior. At TheraNova, this potential is approached with the utmost clinical care. Guided by real-time data and hospital-based safety standards, we support the brain’s capacity to reset its internal pathways not only through biochemical action but also through a process of structured cognitive and emotional reprogramming.